Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris
NCT ID: NCT02219074
Last Updated: 2017-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
350 participants
INTERVENTIONAL
2011-06-30
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris
NCT02217228
Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris
NCT03303170
A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris
NCT02758041
Sebacia Postmarket Study of Real-World Use
NCT03818555
P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris
NCT02242760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sebacia microparticle and laser treatment
Sebacia microparticle and laser treatment
Vehicle and laser treatment
Vehicle and laser treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sebacia microparticle and laser treatment
Vehicle and laser treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnancy, lactating, or planning to become pregnant
* excessive scarring in the treatment area, or other condition that would impact the ability to evaluate acne
16 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sebacia, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Specjalistyczny Gabinet Dermatologiczny
Krakow, , Poland
Military Institute of Health Services
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEB-0005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.